NEURAD LTD has a total of 13 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2016. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are WARNEFORD HEALTHCARE LTD, PHOENIX MOLECULAR DESIGNS and MEZZION PHARMA CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 1 | |
#2 | Brazil | 1 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Hong Kong | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Norway | 1 | |
#10 | New Zealand | 1 | |
#11 | Russian Federation | 1 | |
#12 | United States | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Shubin Kirill | 10 |
#2 | Dax Scott L | 10 |
#3 | Mencel James Joseph | 10 |
#4 | Suna Edgars | 10 |
#5 | Ozola Vita | 10 |
#6 | Vita Ozola | 2 |
#7 | Edgars Suna | 2 |
#8 | James Joseph Mencel | 2 |
#9 | Scott L Dax | 2 |
#10 | Kirill Shubin | 2 |
Publication | Filing date | Title |
---|---|---|
KR20180021868A | Novel respiratory control modulating compounds, and methods of making and using the same |